Global Partners L.P. logo

Global Partners L.P. (GLP)

Market Closed
11 Jun, 18:52
NYSE NYSE
$
54. 42
+0.6
+1.11%
After Hours
$
53. 65
-0.77 -1.41%
1.84B Market Cap
12.15 P/E Ratio
2.38% Div Yield
3,255 Volume
3.9 Eps
$ 53.82
Previous Close
Day Range
53.31 54.73
Year Range
37 60

Summary

GLP closed today higher at $54.42, an increase of 1.11% from yesterday's close, completing a monthly increase of 5.61% or $2.89. Over the past 12 months, GLP stock gained 15.17%.
GLP pays dividends to its shareholders, with the most recent payment made on May 15, 2025. The next estimated payment will be in In 2 months on Aug 15, 2025 for a total of $0.745.
The last earnings report, released on May 06, 2025, exceeded the consensus estimates by 0.39%. On average, the company has surpassed earnings expectations by 0.09%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track GLP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

GLP Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule

Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule

Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (“AEs”) as compared to injected liraglutide (Saxenda®)    Lexaria has now demonstrated, in distinct human clinical studies, clear reductions in AEs utilizing its patented DehydraTECH technology with all of the three major GLP-1 drugs sold in the world today: liraglutide, semaglutide and tirzepatide

Thenewswire | 8 hours ago
Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule

Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule

Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (“AEs”) as compared to injected liraglutide (Saxenda(R))  Lexaria has now demonstrated, in distinct human clinical studies, clear reductions in AEs utilizing its patented DehydraTECH technology with all of the three major GLP-1 drugs sold in the world today: liraglutide, semaglutide and tirzepatide  KELOWNA, BC / ACCESS Newswire / June 11, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce that human study GLP-1-H25-5 (the "Study") which compared oral capsules of DehydraTECH-liraglutide to injected Saxenda®-branded liraglutide has been successfully completed with partial results now available. In distinct clinical human studies, Lexaria has now demonstrated clear reductions in AEs utilizing oral DehydraTECH versions of all three of the major GLP-1 drugs sold in the world today: liraglutide, semaglutide, and tirzepatide.

Accessnewswire | 8 hours ago
Omada Health IPO to Price at $19 a Share as GLP-1s Fuel Interest

Omada Health IPO to Price at $19 a Share as GLP-1s Fuel Interest

Omada Health is making its public-market debut, propelled by Americans' renewed focus on how weight affects physical health.

Wsj | 5 days ago

Global Partners L.P. Dividends

Global Partners L.P. logo
GLP In 1 month
Estimated
Quarterly
$0.74 Per Share
Global Partners L.P. logo
GLP 1 month ago
Paid
Quarterly
$0.74 Per Share
Global Partners L.P. logo
GLP 4 months ago
Paid
Quarterly
$0.74 Per Share
Global Partners L.P. logo
GLP 7 months ago
Paid
Quarterly
$0.73 Per Share
Global Partners L.P. logo
GLP 10 months ago
Paid
Quarterly
$0.72 Per Share
Global Partners L.P. logo
GLP 8 May 2024
Paid
Quarterly
$0.71 Per Share

Global Partners L.P. Earnings

6 May 2025 Date
-
Cons. EPS
0.36
EPS
26 Feb 2025 Date
0.24
Cons. EPS
0.52
EPS
8 Nov 2024 Date
1.57
Cons. EPS
1.17
EPS
7 Nov 2024 Date
1.57
Cons. EPS
-
EPS
7 Aug 2024 Date
1.5
Cons. EPS
1.1
EPS
Global Partners L.P. logo
GLP In 1 month
Estimated
Quarterly
$0.74 Per Share
Global Partners L.P. logo
GLP 1 month ago
Paid
Quarterly
$0.74 Per Share
Global Partners L.P. logo
GLP 4 months ago
Paid
Quarterly
$0.74 Per Share
Global Partners L.P. logo
GLP 7 months ago
Paid
Quarterly
$0.73 Per Share
Global Partners L.P. logo
GLP 10 months ago
Paid
Quarterly
$0.72 Per Share
Global Partners L.P. logo
GLP 8 May 2024
Paid
Quarterly
$0.71 Per Share
6 May 2025 Date
-
Cons. EPS
0.36
EPS
26 Feb 2025 Date
0.24
Cons. EPS
0.52
EPS
8 Nov 2024 Date
1.57
Cons. EPS
1.17
EPS
7 Nov 2024 Date
1.57
Cons. EPS
-
EPS
7 Aug 2024 Date
1.5
Cons. EPS
1.1
EPS

Global Partners L.P. (GLP) FAQ

What is the stock price today?

The current price is $54.42.

On which exchange is it traded?

Global Partners L.P. is listed on NYSE.

What is its stock symbol?

The ticker symbol is GLP.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.84B.

Has Global Partners L.P. ever had a stock split?

No, there has never been a stock split.

Global Partners L.P. Profile

Oil & Gas Midstream Industry
Energy Sector
Mr. Eric S. Slifka CEO
NYSE Exchange
37946R109 Cusip
US Country
3,300 Employees
9 May 2025 Last Dividend
- Last Split
29 Sep 2005 IPO Date

Overview

Global Partners LP is a diverse energy supply company established in 2005, headquartered in Waltham, Massachusetts. The company's core operations encompass the purchase, sale, aggregation, blending, storage, and logistics management of a wide range of petroleum products and renewable fuels. It operates through three primary segments: Wholesale, Gasoline Distribution and Station Operations, and Commercial. By leveraging a comprehensive network of railcars, barges, trucks, and pipelines, Global Partners LP ensures the efficient transportation and delivery of its products to a broad spectrum of wholesalers, retailers, and commercial customers across various sectors.

Products and Services

  • Wholesale

    In its Wholesale segment, the company focuses on the distribution of home heating oil, both branded and unbranded gasoline and gasoline blendstocks, diesel, kerosene, and residual oil. It targets home heating oil and propane retailers along with wholesale distributors. The transportation of these products is facilitated through an extensive network of railcars, barges, trucks, and pipelines, ensuring timely and safe delivery.

  • Gasoline Distribution and Station Operations

    Through the Gasoline Distribution and Station Operations segment, Global Partners LP engages in the sale of branded and unbranded gasoline to operators of gasoline stations and sub-jobbers. It also manages gasoline stations and convenience stores, offering a range of services including car wash, lottery, and ATM facilities. Additionally, the company’s operations include the leasing of gasoline stations to third parties.

  • Commercial

    The Commercial segment of the business caters to a diverse clientele including public sector entities, commercial industries, and industrial end-users. It supplies unbranded gasoline, home heating oil, diesel, kerosene, residual oil, and bunker fuel. Global Partners LP is also known for selling custom blended fuels tailored to specific customer requirements. This segment underscores the company’s ability to meet the specialized needs of its commercial and industrial customers.

  • Transportation of Petroleum Products and Renewable Fuels

    Besides its main trading activities, Global Partners LP is significantly involved in the transportation sector, specifically in the movement of petroleum products and renewable fuels. Leveraging rail transportation, the company facilitates the efficient movement of these products from the mid-continent region of the United States and Canada, highlighting its logistical capabilities and commitment to ensuring a steady supply of energy resources.

Contact Information

Address: 800 South Street
Phone: 781 894 8800